Canada markets closed

Rapid Dose Therapeutics Corp. (DOSE.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.2250+0.0150 (+7.14%)
At close: 3:57PM EST

Rapid Dose Therapeutics Corp.

1121 Walkers Line
Unit 3A
Burlington, ON L7N 2G4
Canada
416 477 1052
http://www.rapid-dose.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Mark Andrew UpsdellChairman, Pres & CEO344.31kN/AN/A
Mr. Jason LewisSr. VP of Bus. Devel. & Director195.03kN/AN/A
Rishi KapadiaCFO & ControllerN/AN/AN/A
Mr. Donald Alexander R. Sheldon L.L.B., B.A.Sc., M.A.Sc., P.Eng., LL.BLegal CounselN/AN/A1947
Mr. Miles A. Nagamatsu C.A., CPA, CA, CPAConsultantN/AN/A1956
Jorge EstepaAssistant Corp. Sec.N/AN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies designed to enhance outcomes and quality of lives in Canada. The company offers QuickStrip, an oral fast-dissolving drug delivery system to rapidly release active ingredients into the blood stream, such as pharmaceuticals, emulsified oils, and over-the-counter medicines; QuickStrip energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12 in the system; and QuickStrip sleep that delivers melatonin in the system. It also offers PharmaStrip delivery system. The company also provides product innovation, production, and consultation services to the nutraceutical, cannabis healthcare, and pharmaceutical manufacturing industries. It has a research partnership program with McMaster University for developing biopolymer compositions that can offer enhanced drug delivery performance when formulated in oral dissolvable thin films. Rapid Dose Therapeutics Corp. is based in Burlington, Canada.

Corporate Governance

Rapid Dose Therapeutics Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.